MedTrace Logo

Does Skyla Insertion Timing Impact Bleeding?

NCT03074903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2018-02-13

No results posted yet for this study

Summary

Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.

Conditions

  • Vaginal Bleeding

Interventions

DEVICE

Intrauterine system

Women having the Skyla intrauterine system at different times during their menstrual cycle report their bleeding patterns through daily texts.

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Noa'a Shimoni, MD MPH · Rutgers University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-16
Primary Completion
2017-07-27
Completion
2017-07-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03074903 on ClinicalTrials.gov